JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 30, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/14/10913    most recent
M010975200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanathan, Y.
Right arrow Articles by Pe'ery, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanathan, Y.
Right arrow Articles by Pe'ery, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 16, 2001
J. Biol. Chem, 10.1074/jbc.M010975200
Submitted on December 5, 2000
Revised on January 16, 2001
Accepted on January 15, 2001

Three RNA polymerase II carboxy-terminal domain kinases display distinct Substrate preferences

Y. Ramanathan, Sanjay M. Rajpara, Syed M. Reza, Emma Lees, Stewart Shuman, Michael B. Mathews, and Tsafi Pe'ery

Biochemistry & Molecular Biology, NJ Medical School-UMDNJ, Newark, NJ 07103-2714

Corresponding Author: peeryts{at}umdnj.edu

CDK7, CDK8 and CDK9 are cyclin-dependent kinases (CDKs) that phosphorylate the carboxy-terminal domain (CTD) of RNA polymerase II. They have distinct functions in transcription. Since the three CDKs target only serine-5 in the heptad repeat of model CTD substrates containing various numbers of repeats, we tested the hypothesis that the kinases differ in their ability to phosphorylate CTD heptad arrays. Our data show that the kinases display different preferences for phosphorylating individual heptads in a synthetic CTD substrate containing three heptamer repeats and specific regions of the CTD in glutathione S-transferase (GST) fusion proteins. They also exhibit differences in their ability to phosphorylate a synthetic CTD peptide that contains Ser-2-PO4. This phosphorylated peptide is a poor substrate for CDK9 complexes. CDK8 and CDK9 complexes bound to viral activators E1A and Tat respectively, target only serine 5 for phosphorylation in the CTD peptides and binding to the viral activators does not change the substrate preference of these kinases. These results imply that the display of different CTD heptads during transcription, as well as their phosphorylation state, can affect their phosphorylation by the different transcription-associated CDKs.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Biol EvolHome page
P. Liu, A. L. Greenleaf, and J. W. Stiller
The Essential Sequence Elements Required for RNAP II Carboxyl-terminal Domain Function in Yeast and Their Evolutionary Conservation
Mol. Biol. Evol., April 1, 2008; 25(4): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Ni, A. Saunders, N. J. Fuda, J. Yao, J.-R. Suarez, W. W. Webb, and J. T. Lis
P-TEFb Is Critical for the Maturation of RNA Polymerase II into Productive Elongation In Vivo
Mol. Cell. Biol., February 1, 2008; 28(3): 1161 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Fujita, S. Ryser, S. Tortola, I. Piuz, and W. Schlegel
Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells
Nucleic Acids Res., February 16, 2007; 35(3): 1007 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Gao, L. Kramer, M. Rahmani, P. Dent, and S. Grant
The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism
Mol. Pharmacol., August 1, 2006; 70(2): 645 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Moisan and L. Gaudreau
The BRCA1 COOH-terminal Region Acts as an RNA Polymerase II Carboxyl-terminal Domain Kinase Inhibitor That Modulates p21WAF1/CIP1 Expression
J. Biol. Chem., July 28, 2006; 281(30): 21119 - 21130.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Wood and A. Shilatifard
Transcriptional blackjack with p21.
Genes & Dev., March 15, 2006; 20(6): 643 - 647.
[Full Text] [PDF]


Home page
Genes Dev.Home page
N. P. Gomes, G. Bjerke, B. Llorente, S. A. Szostek, B. M. Emerson, and J. M. Espinosa
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Genes & Dev., March 1, 2006; 20(5): 601 - 612.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Pei, H. Du, J. Singer, C. St. Amour, S. Granitto, S. Shuman, and R. P. Fisher
Cyclin-Dependent Kinase 9 (Cdk9) of Fission Yeast Is Activated by the CDK-Activating Kinase Csk1, Overlaps Functionally with the TFIIH-Associated Kinase Mcs6, and Associates with the mRNA Cap Methyltransferase Pcm1 In Vivo
Mol. Cell. Biol., February 1, 2006; 26(3): 777 - 788.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. P. Fisher
Secrets of a double agent: CDK7 in cell-cycle control and transcription
J. Cell Sci., November 15, 2005; 118(22): 5171 - 5180.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. A. Fraser and S. A. Rice
Herpes Simplex Virus Type 1 Infection Leads to Loss of Serine-2 Phosphorylation on the Carboxyl-Terminal Domain of RNA Polymerase II
J. Virol., September 1, 2005; 79(17): 11323 - 11334.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Pennati, A. J. Campbell, M. Curto, M. Binda, Y. Cheng, L.-Z. Wang, N. Curtin, B. T. Golding, R. J. Griffin, I. R. Hardcastle, et al.
Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
Mol. Cancer Ther., September 1, 2005; 4(9): 1328 - 1337.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Meinhart, T. Kamenski, S. Hoeppner, S. Baumli, and P. Cramer
A structural perspective of CTD function
Genes & Dev., June 15, 2005; 19(12): 1401 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Byers, J. P. Price, J. J. Cooper, Q. Li, and D. H. Price
HEXIM2, a HEXIM1-related Protein, Regulates Positive Transcription Elongation Factor b through Association with 7SK
J. Biol. Chem., April 22, 2005; 280(16): 16360 - 16367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hoque, B. Tian, M. B. Mathews, and T. Pe'ery
Granulin and Granulin Repeats Interact with the Tat{middle dot}P-TEFb Complex and Inhibit Tat Transactivation
J. Biol. Chem., April 8, 2005; 280(14): 13648 - 13657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Millhouse and J. L. Manley
The C-Terminal Domain of RNA Polymerase II Functions as a Phosphorylation-Dependent Splicing Activator in a Heterologous Protein
Mol. Cell. Biol., January 15, 2005; 25(2): 533 - 544.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. B. Wilcox, A. Rossettini, and S. D. Hanes
Genetic Interactions With C-Terminal Domain (CTD) Kinases and the CTD of RNA Pol II Suggest a Role for ESS1 in Transcription Initiation and Elongation in Saccharomyces cerevisiae
Genetics, May 1, 2004; 167(1): 93 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Inukai, Y. Yamaguchi, I. Kuraoka, T. Yamada, S. Kamijo, J. Kato, K. Tanaka, and H. Handa
A Novel Hydrogen Peroxide-induced Phosphorylation and Ubiquitination Pathway Leading to RNA Polymerase II Proteolysis
J. Biol. Chem., February 27, 2004; 279(9): 8190 - 8195.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. K. Boehm, A. Saunders, J. Werner, and J. T. Lis
Transcription Factor and Polymerase Recruitment, Modification, and Movement on dhsp70 In Vivo in the Minutes following Heat Shock
Mol. Cell. Biol., November 1, 2003; 23(21): 7628 - 7637.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M.-C. Keogh, V. Podolny, and S. Buratowski
Bur1 Kinase Is Required for Efficient Transcription Elongation by RNA Polymerase II
Mol. Cell. Biol., October 1, 2003; 23(19): 7005 - 7018.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Bako, M. Umeda, A. F. Tiburcio, J. Schell, and C. Koncz
The VirD2 pilot protein of Agrobacterium-transferred DNA interacts with the TATA box-binding protein and a nuclear protein kinase in plants
PNAS, August 19, 2003; 100(17): 10108 - 10113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yeo, P. S. Lin, M. E. Dahmus, and G. N. Gill
A Novel RNA Polymerase II C-terminal Domain Phosphatase That Preferentially Dephosphorylates Serine 5
J. Biol. Chem., July 3, 2003; 278(28): 26078 - 26085.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. S. Lin, M.-F. Dubois, and M. E. Dahmus
TFIIF-associating Carboxyl-terminal Domain Phosphatase Dephosphorylates Phosphoserines 2 and 5 of RNA Polymerase II
J. Biol. Chem., November 22, 2002; 277(48): 45949 - 45956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Borggrefe, R. Davis, H. Erdjument-Bromage, P. Tempst, and R. D. Kornberg
A Complex of the Srb8, -9, -10, and -11 Transcriptional Regulatory Proteins from Yeast
J. Biol. Chem., November 8, 2002; 277(46): 44202 - 44207.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. K. Kim, C. F. Bourgeois, C. Isel, M. J. Churcher, and J. Karn
Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation
Mol. Cell. Biol., July 1, 2002; 22(13): 4622 - 4637.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
G. Prelich
RNA Polymerase II Carboxy-Terminal Domain Kinases: Emerging Clues to Their Function
Eukaryot. Cell, April 1, 2002; 1(2): 153 - 162.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Hoque, T. M. Young, C.-G. Lee, G. Serrero, M. B. Mathews, and T. Pe'ery
The Growth Factor Granulin Interacts with Cyclin T1 and Modulates P-TEFb-Dependent Transcription
Mol. Cell. Biol., March 1, 2002; 23(5): 1688 - 1702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. West, A. D. Lowe, and J. Karn
Activation of Human Immunodeficiency Virus Transcription in T Cells Revisited: NF-{kappa}B p65 Stimulates Transcriptional Elongation
J. Virol., September 15, 2001; 75(18): 8524 - 8537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhou, S. Nekhai, D. C. Bharucha, A. Kumar, H. Ge, D. H. Price, J.-M. Egly, and J. N. Brady
TFIIH Inhibits CDK9 Phosphorylation during Human Immunodeficiency Virus Type 1 Transcription
J. Biol. Chem., November 21, 2001; 276(48): 44633 - 44640.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.